Start New EnglishEspañol中文РусскийالعربيةTiếng ViệtFrançaisDeutsch한국어Tagalog Library Performance
BETA v.3.0

2025 ICD-10-CM code Q85.02

Neurofibromatosis, type 2; Acoustic neurofibromatosis.

Codes from chapter Q are not for use on maternal records.Ensure appropriate documentation supports the diagnosis.

Medical necessity for coding Q85.02 is established by the presence of clinical findings or genetic confirmation consistent with Neurofibromatosis type 2.Management may include surgical intervention, radiation therapy, and/or monitoring for tumor growth.

Diagnosis and management of neurofibromatosis type 2, including genetic counseling, tumor surveillance, and treatment of associated symptoms.

IMPORTANT:Excludes1: ataxia telangiectasia [Louis-Bar] (G11.3); familial dysautonomia [Riley-Day] (G90.1)

In simple words: Q85.02 is a code for a rare inherited condition called Neurofibromatosis type 2.This condition causes non-cancerous tumors to grow on the nerves in the head and spine.

Q85.02 is an ICD-10-CM code that classifies Neurofibromatosis, type 2, also known as acoustic neurofibromatosis.This is a genetic disorder characterized by the development of benign tumors on cranial and spinal nerves. It is less common than Neurofibromatosis type 1.

Example 1: A 25-year-old patient presents with progressive hearing loss and tinnitus. Imaging reveals bilateral vestibular schwannomas, consistent with Neurofibromatosis type 2. Code Q85.02 is used to document the diagnosis., A 40-year-old patient with a known diagnosis of Neurofibromatosis type 2 undergoes surgical resection of a spinal nerve schwannoma. Code Q85.02 is used to document the underlying condition., A 30-year-old patient with a family history of Neurofibromatosis type 2 undergoes genetic testing, confirming the diagnosis. Code Q85.02 is used to document the diagnosis even in the absence of overt symptoms.

Detailed family history of Neurofibromatosis type 2; imaging studies (MRI, CT) demonstrating characteristic tumors; genetic testing results (if performed).

** This code is specific to Neurofibromatosis type 2 and should not be used for other types of neurofibromatosis or related conditions.Always ensure accurate and comprehensive documentation to support the use of this code.

** Only Enterprise users with EHR integration can access case-specific answers. Click here to request access.

Discover what matters.

iFrame™ AI's knowledge is aligned with and limited to the materials uploaded by users and should not be interpreted as medical, legal, or any other form of advice by iFrame™.